中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
16期
36-37
,共2页
米非司酮%新生化片%胎盘残留
米非司酮%新生化片%胎盤殘留
미비사동%신생화편%태반잔류
Mifepristone%New biochemical tablets%Residual placenta
探讨米非司酮配伍新生化片治疗胎盘残留的可行性及可靠性。方法将符合条件的患者随机分成两组:观察组50例,米非司酮50 mg口服1次/12 h,共6次,配伍新生化片12片/d,分3次服用,服用5 d;对照组50例产后生化汤1剂/d,分2次服用,服用5d。对两组的治疗效果进行比较。结果观察组与对照组相比,完全排除例数、阴道出血干净时间、清宫率差异有统计学意义(P<0.05)。结论米非司酮配伍新生化片帮助产后宫内残留排出,减少产后清宫和晚期产后出血的发生,减轻了病人的痛苦,疗效肯定,值得临床推广应用。
探討米非司酮配伍新生化片治療胎盤殘留的可行性及可靠性。方法將符閤條件的患者隨機分成兩組:觀察組50例,米非司酮50 mg口服1次/12 h,共6次,配伍新生化片12片/d,分3次服用,服用5 d;對照組50例產後生化湯1劑/d,分2次服用,服用5d。對兩組的治療效果進行比較。結果觀察組與對照組相比,完全排除例數、陰道齣血榦淨時間、清宮率差異有統計學意義(P<0.05)。結論米非司酮配伍新生化片幫助產後宮內殘留排齣,減少產後清宮和晚期產後齣血的髮生,減輕瞭病人的痛苦,療效肯定,值得臨床推廣應用。
탐토미비사동배오신생화편치료태반잔류적가행성급가고성。방법장부합조건적환자수궤분성량조:관찰조50례,미비사동50 mg구복1차/12 h,공6차,배오신생화편12편/d,분3차복용,복용5 d;대조조50례산후생화탕1제/d,분2차복용,복용5d。대량조적치료효과진행비교。결과관찰조여대조조상비,완전배제례수、음도출혈간정시간、청궁솔차이유통계학의의(P<0.05)。결론미비사동배오신생화편방조산후궁내잔류배출,감소산후청궁화만기산후출혈적발생,감경료병인적통고,료효긍정,치득림상추엄응용。
To explore the feasibility and reliability of mifepristone combined with new biochemical tablets in the treat-ment of residual placenta. Methods The eligible patients were randomly divided into two groups:50 cases in the observation group were given oral administration of mifepristone 50mg 1/12h, for a total of 6 times, compatibility of oral administration of new bio-chemical tablets 12 tablets / day, divided into 3 doses, for 5d; 50 cases in the control group were given postpartum biochemical soup, 1 doze which divided into 2 halves one day, for 5d. The therapeutic effects of the two groups were compared. Results The differences in totally excluded cases, vaginal bleeding time and the rate of curettage between the observation group and the control group were statistically significant (P<0.05). Conclusion Mifepristone and new biochemical tablets can help discharge postpartum intrauterine residue, reduce the incidence of postpartum curettage and late postpartum hemorrhage, relieve the pain of the patients with definite curative effect, which are worthy of clinical application.